Interdisciplinary Perspectives on Infectious Diseases / 2009 / Article / Fig 6

Review Article

Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs

Figure 6

Trypanosoma cruzi epimastigotes treated with ketoconazole, an inhibitor of the C -demetilase (a)-(b), and L. amazonensis promastigotes treated with E5700, an inhibitor of the squalene synthase (c) showing an intense mitochondrial swelling (a)-(b) and alterations in the kinetoplast structure ((c), arrowhead). K, kinetoplast; M, mitochondrion. (a)-(b) Images are reproduced with permission from [74] American Society for Microbiology. Bars, m.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.